(R) CHOSA - The market now doubles for Platin-DRP®, which predicts overall survival in lung cancer patients based on NanoString data

Read more

(R) CHOSA - Marknaden dubbleras nu för Platin-DRP® som förutsäger totalöverlevnad hos patienter med lungcancer genom NanoString-data

Read more

(R) CHOSA Oncology AB – Kvartalsrapport juli-sept 2025.

Read more

CHOSA - Platinum chemotherapy is the backbone of PD-1/PD-L1-based lung cancer therapy

Read more

CHOSA - Platinabaserad kemoterapi är ryggraden i PD-1/PD-L1-baserad lungcancerbehandling

Read more

CHOSA’s presented data on the carboplatin response predictor in breast cancer patients on the ESMO conference

Read more

CHOSA presenterade om carboplatin-respons-prediktorn hos bröstcancerpatienter på ESMO-konferensen

Read more

CHOSA Wins 2025 Jiangning International Entrepreneurship Contest (Greater Shanghai region), China

Read more

CHOSA vinner 2025 års Jiangning International Entrepreneurship Contest (Greater Shanghai region), Kina

Read more

(R) CHOSA announces positive results from a clinical study in collaboration with ETOP/EORTC on platinum predictor in lung cancer

Read more

(R) CHOSA presenterar positiva resultat från en klinisk studie i samarbete med ETOP/EORTC kring platin-prediktor i lungcancer

Read more

(R) CHOSA Oncology AB – Kvartalsrapport april-juni 2025.

Read more